Androgen-deprivation therapy for prostate cancer.
Higano
Celestia
C
D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy / Q000379:methods; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D016019:Survival Analysis
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen